Literature DB >> 22144472

The evolution of endothelial regulatory paradigms in cancer biology and vascular repair.

Joseph W Franses1, Elazer R Edelman.   

Abstract

Although the roles of endothelial cells in cancer have primarily been considered to be related to tumor perfusion, the emerging appreciation of "angiocrine" regulation adds stromal regulatory capabilities to the expanding list of endothelial functions in tumors. We posit that an understanding of the state-dependent paracrine regulatory paradigms established in vascular disease and repair will be critical for a deep understanding of tumor biology, as endothelial cells regulate diverse processes in all vascularized tissues. Here, we outline the historical developments that led to the appreciation of the paracrine regulatory functions of endothelial cells, summarize classical views of blood vessels and stroma in cancer, and attempt to merge these ideas to include the stromal regulatory endothelial cell as a critical regulator of cancer. The notion of the endothelial cell as a biochemical regulator of cancer state in constant dynamic balance with its tumor could impact diagnosis, prognosis, and treatment of cancer. Such concepts might well explain the mixed results from antiangiogenic cancer therapeutics and how certain drugs that improve vascular health correlate with improved cancer prognosis.

Entities:  

Mesh:

Year:  2011        PMID: 22144472      PMCID: PMC3242853          DOI: 10.1158/0008-5472.CAN-11-1718

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

Review 1.  Endothelial cell biology: role in the inflammatory response.

Authors:  Mariah Pate; Vijay Damarla; David S Chi; Smita Negi; Guha Krishnaswamy
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

2.  Molecular heterogeneity of tumor endothelium.

Authors:  William C Aird
Journal:  Cell Tissue Res       Date:  2008-08-23       Impact factor: 5.249

3.  Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate airway repair.

Authors:  Brett G Zani; Koji Kojima; Charles A Vacanti; Elazer R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

4.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis.

Authors:  A C Barger; R Beeuwkes; L L Lainey; K J Silverman
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

Review 5.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

6.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 7.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

Review 8.  Can cancer be reversed by engineering the tumor microenvironment?

Authors:  Donald E Ingber
Journal:  Semin Cancer Biol       Date:  2008-04-01       Impact factor: 15.707

Review 9.  Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.

Authors:  Hang Xiao; Chung S Yang
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

10.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

View more
  13 in total

1.  Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.

Authors:  Zainab A Bazzi; Jennifer Balun; Dora Cavallo-Medved; Lisa A Porter; Michael B Boffa
Journal:  Clin Exp Metastasis       Date:  2017-01-25       Impact factor: 5.150

2.  Quantitative phosphoproteomics analysis reveals broad regulatory role of heparan sulfate on endothelial signaling.

Authors:  Hong Qiu; Jun-Lin Jiang; Miao Liu; Xin Huang; Shi-Jian Ding; Lianchun Wang
Journal:  Mol Cell Proteomics       Date:  2013-05-06       Impact factor: 5.911

3.  Tumor endothelial inflammation predicts clinical outcome in diverse human cancers.

Authors:  Sean P Pitroda; Tong Zhou; Randy F Sweis; Matthew Filippo; Edwardine Labay; Michael A Beckett; Helena J Mauceri; Hua Liang; Thomas E Darga; Samantha Perakis; Sajid A Khan; Harold G Sutton; Wei Zhang; Nikolai N Khodarev; Joe G N Garcia; Ralph R Weichselbaum
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

4.  Cycling hypoxia induces a specific amplified inflammatory phenotype in endothelial cells and enhances tumor-promoting inflammation in vivo.

Authors:  Céline Tellier; Déborah Desmet; Laurenne Petit; Laure Finet; Carlos Graux; Martine Raes; Olivier Feron; Carine Michiels
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

5.  The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting.

Authors:  Zhi Hong Lu; Sergey Kaliberov; Jingzhu Zhang; Barbara Muz; Abdel K Azab; Rebecca E Sohn; Lyudmila Kaliberova; Yingqiu Du; David T Curiel; Jeffrey M Arbeit
Journal:  Lab Invest       Date:  2014-06-23       Impact factor: 5.662

6.  Lymphatic endothelial cells support tumor growth in breast cancer.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Sci Rep       Date:  2014-07-28       Impact factor: 4.379

Review 7.  Vascular normalisation as the stepping stone into tumour microenvironment transformation.

Authors:  Anette L Magnussen; Ian G Mills
Journal:  Br J Cancer       Date:  2021-04-07       Impact factor: 7.640

8.  Dying endothelial cells stimulate proliferation of malignant glioma cells via a caspase 3-mediated pathway.

Authors:  Ping Mao; Luke Smith; Wanfu Xie; Maode Wang
Journal:  Oncol Lett       Date:  2013-03-01       Impact factor: 2.967

9.  Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis.

Authors:  Zhi-Yuan Chen; Ming Shi; Li-Xia Peng; Wei Wei; Xin-Jian Li; Zhi-Xing Guo; Shu-Hong Li; Chong Zhong; Chao-Nan Qian; Rong-Ping Guo
Journal:  J Transl Med       Date:  2012-12-10       Impact factor: 5.531

10.  Dll4-notch signalling blockade synergizes combined ultrasound-stimulated microbubble and radiation therapy in human colon cancer xenografts.

Authors:  Ahmed El Kaffas; Joris Nofiele; Anoja Giles; Song Cho; Stanley K Liu; Gregory J Czarnota
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.